GSA Capital Partners’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $819K | Buy |
141,936
+112,914
| +389% | +$652K | 0.06% | 583 |
|
2025
Q1 | $192K | Sell |
29,022
-60,283
| -68% | -$399K | 0.02% | 1403 |
|
2024
Q4 | $778K | Buy |
+89,305
| New | +$778K | 0.06% | 578 |
|
2023
Q4 | – | Sell |
-11,039
| Closed | -$101K | – | 1727 |
|
2023
Q3 | $101K | Sell |
11,039
-98,156
| -90% | -$898K | 0.01% | 1387 |
|
2023
Q2 | $1.16M | Buy |
+109,195
| New | +$1.16M | 0.12% | 239 |
|
2022
Q4 | – | Sell |
-14,497
| Closed | -$198K | – | 1689 |
|
2022
Q3 | $198K | Buy |
+14,497
| New | +$198K | 0.03% | 1232 |
|
2022
Q1 | – | Sell |
-12,284
| Closed | -$172K | – | 1630 |
|
2021
Q4 | $172K | Buy |
+12,284
| New | +$172K | 0.02% | 1249 |
|